XOMA Corp (XOMA) - Total Liabilities
Based on the latest financial reports, XOMA Corp (XOMA) has total liabilities worth $155.19 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore XOMA Corp cash conversion from operations to assess how effectively this company generates cash.
XOMA Corp - Total Liabilities Trend (1985–2024)
This chart illustrates how XOMA Corp's total liabilities have evolved over time, based on quarterly financial data. Check XOMA Corp liquid asset ratio to evaluate the company's liquid asset resilience ratio.
XOMA Corp Competitors by Total Liabilities
The table below lists competitors of XOMA Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SNDL INC.
F:VY4
|
Germany | €241.90 Million |
|
eDreams Odigeo SA
MC:EDR
|
Spain | €860.06 Million |
|
enCore Energy Corp.
V:EU
|
Canada | CA$164.15 Million |
|
Novabase SGPS
LS:NBA
|
Portugal | €67.78 Million |
|
Hiyes International Co Ltd
TW:2348
|
Taiwan | NT$36.70 Billion |
|
BGF Retail Co Ltd
KO:027410
|
Korea | ₩345.67 Billion |
|
Alfas Solar Enerji Sanayi ve Ticaret A.S.
IS:ALFAS
|
Turkey | TL6.48 Billion |
|
Daishin Securities Co Ltd Pref
KO:003545
|
Korea | ₩29.90 Trillion |
Liability Composition Analysis (1985–2024)
This chart breaks down XOMA Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see XOMA Corp market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how XOMA Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for XOMA Corp (1985–2024)
The table below shows the annual total liabilities of XOMA Corp from 1985 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $139.36 Million | -4.28% |
| 2023-12-31 | $145.58 Million | +789.42% |
| 2022-12-31 | $16.37 Million | -33.70% |
| 2021-12-31 | $24.69 Million | -36.48% |
| 2020-12-31 | $38.86 Million | -24.89% |
| 2019-12-31 | $51.74 Million | +14.97% |
| 2018-12-31 | $45.00 Million | +14.95% |
| 2017-12-31 | $39.15 Million | -48.41% |
| 2016-12-31 | $75.89 Million | -1.69% |
| 2015-12-31 | $77.19 Million | -10.80% |
| 2014-12-31 | $86.53 Million | -37.64% |
| 2013-12-31 | $138.77 Million | +64.79% |
| 2012-12-31 | $84.21 Million | +33.61% |
| 2011-12-31 | $63.02 Million | +24.41% |
| 2010-12-31 | $50.66 Million | +43.52% |
| 2009-12-31 | $35.30 Million | -64.19% |
| 2008-12-31 | $98.57 Million | +16.66% |
| 2007-12-31 | $84.50 Million | -34.83% |
| 2006-12-31 | $129.65 Million | +39.04% |
| 2005-12-31 | $93.25 Million | +31.58% |
| 2004-12-31 | $70.87 Million | +0.33% |
| 2003-12-31 | $70.64 Million | -15.05% |
| 2002-12-31 | $83.15 Million | +14.70% |
| 2001-12-31 | $72.49 Million | +34.73% |
| 2000-12-31 | $53.80 Million | +19.03% |
| 1999-12-31 | $45.20 Million | +21.83% |
| 1998-12-31 | $37.10 Million | +10.42% |
| 1997-12-31 | $33.60 Million | +46.09% |
| 1996-12-31 | $23.00 Million | +63.12% |
| 1995-12-31 | $14.10 Million | -25.40% |
| 1994-12-31 | $18.90 Million | +20.38% |
| 1993-12-31 | $15.70 Million | -24.52% |
| 1992-12-31 | $20.80 Million | +5.05% |
| 1991-12-31 | $19.80 Million | -71.95% |
| 1990-12-31 | $70.60 Million | -15.35% |
| 1989-12-31 | $83.40 Million | +230.95% |
| 1988-12-31 | $25.20 Million | -10.00% |
| 1987-12-31 | $28.00 Million | -20.90% |
| 1986-12-31 | $35.40 Million | +1866.67% |
| 1985-12-31 | $1.80 Million | -- |
About XOMA Corp
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential… Read more